Assessment of repurposed compounds against coronaviruses highlights the antiviral broad-spectrum activity of host-targeting iminosugars and confirms the activity of potent directly acting antivirals
The COVID-19 pandemic highlights the need for novel antiviral drug discovery approaches that could dramatically shorten timelines from compound discovery to clinical development. At the beginning of the pandemic, repurposing approaches were at the forefront of early research efforts to screen for an...
Κύριοι συγγραφείς: | Brun, J, Arman, BY, Hill, ML, Kiappes, JL, Alonzi, DS, Makower, LL, Witt, KD, Gileadi, C, Rangel, V, Dwek, RA, Von Delft, A, Zitzmann, N |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Elsevier
2025
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Iminosugar antivirals: the therapeutic sweet spot
ανά: Alonzi, D, κ.ά.
Έκδοση: (2017) -
Antiviral effects of deoxynojirimycin (DNJ)-based iminosugars in dengue virus-infected primary dendritic cells
ανά: Perera, N, κ.ά.
Έκδοση: (2022) -
Antiviral effects of an iminosugar derivative on flavivirus infections.
ανά: Wu, S, κ.ά.
Έκδοση: (2002) -
Mechanisms of antiviral activity of iminosugars against dengue virus
ανά: Miller, JL, κ.ά.
Έκδοση: (2018) -
Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4
ανά: Warfield, KL, κ.ά.
Έκδοση: (2016)